Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T M Illidge

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
Clinical Oncology (Royal College of Radiologists (Great Britain))|April 17, 1998
Radiation-induced apoptosisT M Illidge
Clinical Oncology (Royal College of Radiologists (Great Britain))|June 4, 1998
The Junior Radiology Forum: What do the trainees think about the future of oncology training?T M Illidge
Current Pharmaceutical Design|July 21, 2000
Radioimmunotherapy of cancer: using monoclonal antibodies to target radiotherapyT M Illidge, S Brock
Expert Opinion on Pharmacotherapy|October 5, 2001
Antibody therapy of lymphomaT M Illidge, M C Bayne
Oncoimmunology|July 4, 2015
The antitumor immune response generated by fractionated radiation therapy may be limited by tumor cell adaptive resistance and can be circumvented by PD-L1 blockadeS J Dovedi, T M Illidge
BMJ (Clinical Research Ed.)|November 14, 1992
EuthanasiaT M Illidge, S R Kirkham
British Journal of Haematology|May 3, 2000
The emerging role of radioimmunotherapy in haematological malignanciesT M Illidge, P W Johnson
Clinical Oncology (Royal College of Radiologists (Great Britain))|November 22, 2001
Hypercalcaemia, parathyroid hormone-related protein and malignancyM C Bayne, T M Illidge
Clinical Oncology (Royal College of Radiologists (Great Britain))|May 20, 2005
What's new in the management of cutaneous T-cell lymphoma?V McFarlane, P S Friedmann, T M Illidge
Clinical Oncology (Royal College of Radiologists (Great Britain))|January 1, 1996
Malignant hypercalcaemia in pregnancy and antenatal administration of intravenous pamidronateT M Illidge, M Hussey, C W Godden
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Clinical Oncology (Royal College of Radiologists (Great Britain))|April 17, 1998
Radiation-induced apoptosisT M Illidge
Clinical Oncology (Royal College of Radiologists (Great Britain))|June 4, 1998
The Junior Radiology Forum: What do the trainees think about the future of oncology training?T M Illidge
Current Pharmaceutical Design|July 21, 2000
Radioimmunotherapy of cancer: using monoclonal antibodies to target radiotherapyT M Illidge, S Brock
Expert Opinion on Pharmacotherapy|October 5, 2001
Antibody therapy of lymphomaT M Illidge, M C Bayne
Oncoimmunology|July 4, 2015
The antitumor immune response generated by fractionated radiation therapy may be limited by tumor cell adaptive resistance and can be circumvented by PD-L1 blockadeS J Dovedi, T M Illidge
BMJ (Clinical Research Ed.)|November 14, 1992
EuthanasiaT M Illidge, S R Kirkham
British Journal of Haematology|May 3, 2000
The emerging role of radioimmunotherapy in haematological malignanciesT M Illidge, P W Johnson
Clinical Oncology (Royal College of Radiologists (Great Britain))|November 22, 2001
Hypercalcaemia, parathyroid hormone-related protein and malignancyM C Bayne, T M Illidge
Clinical Oncology (Royal College of Radiologists (Great Britain))|May 20, 2005
What's new in the management of cutaneous T-cell lymphoma?V McFarlane, P S Friedmann, T M Illidge
Clinical Oncology (Royal College of Radiologists (Great Britain))|January 1, 1996
Malignant hypercalcaemia in pregnancy and antenatal administration of intravenous pamidronateT M Illidge, M Hussey, C W Godden
Pageof 3